leading glp-1 treatments for diabetes 2025 How Employers Can Manage Costs in Their Health Plans GLP-1s and Diabetes Care: What

New entrants to this market could drive prices down, but I worry that if a few companies continue to represent virtually all of the market, they will maintain their price discipline and the costs of these medications will leave them out of reach for many who could benefit from them

Like, Oh, really

According to market research, the skin lightening industry was valued at over $8 billion in 2022 and continues to expand, particularly in Asia, the Middle East, and among diverse populations in Western countries seeking solutions for PIH caused by acne or irritation 1

Making a decision about loose skin procedures post-GLP-1 requires more than curiosity

The staff here have been awesome